Cell & Gene Therapies

(Image: Getty/wildpixel)

CAR-T for solid tumors drives industry to innovate

By Maggie Lynch

ICT is developing upon CAR-T cell technology to enable T-cells to persist against cancer’s attempt to program death into a patient’s defensive T-cells, which could potentially treat solid tumors.

(Image: Getty/exdez)

bioProcessUK Conference

Outgoing GSK exec shares four industry mega-trends

By Flora Southey

A number of global ‘mega-trends’, such as dated technology and manufacturing inefficiencies, present major challenges for the drug industry, according to Dave Tudor

(Image: Getty/Luka Banda)

BIA Bioscience Forum

Four major barriers to efficient cell & gene manufacture

By Ben Hargreaves

BIA’s Bioscience Forum brought together four experts on cell and gene manufacture to discuss what difficulties are being faced in the industry and how they are reacting to them.